Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.
- L. Ahdieh, R. Klein, +7 authors K. Shah
- Biology, Medicine
- The Journal of infectious diseases
- 15 September 2001
HIV infection and immunosuppression play an important role in modulating the natural history of HPV infection as well as risk factors for HPV persistence. Expand
Marriage, monogamy and HIV: a profile of HIV-infected women in south India
HIV prevention and intervention strategies need to focus on married, monogamous Indian women whose self-perception of HIV risk may be low, but whose risk is inextricably linked to the behaviour of their husbands. Expand
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.
- H. Strickler, J. Palefsky, +16 authors R. Burk
- Journal of the National Cancer Institute
- 16 July 2003
The prevalent and incident detection of HPV16 is more weakly associated with immune status in HIV-seropositive women than that of other HPV types, suggesting that HPV16 may be better at avoiding the effects of immune surveillance, which could contribute to HPV16's strong association with cervical cancer. Expand
Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature
- P. Chan, A. Robinette, +6 authors E. Hardy
- Infectious diseases in obstetrics and gynecology
- 5 June 2016
This work reviewed studies reporting the prevalence of extragenital infections in women, men who have sex with men (MSM), and menWho have sex only with women (MSW), including distribution by anatomical site, and discussed current clinical recommendations and future directions for research. Expand
Trappin‐2/Elafin: a novel innate anti‐human immunodeficiency virus‐1 molecule of the human female reproductive tract
- M. Ghosh, Zheng Shen, J. Fahey, S. Cu-Uvin, K. Mayer, C. Wira
- Biology, Medicine
- 1 February 2010
The data suggest that Trappin‐2/Elafin might be an important endogenous microbicide of the female reproductive tract that is protective against HIV‐1. Expand
Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya
- K. Khozaim, Elkanah Omenge Orang'o, +9 authors Sierra Washington
- International journal of gynaecology and…
- 1 January 2014
To describe the challenges and successes of integrating a public‐sector cervical screening program into a large HIV care system in western Kenya, scientists used a large database of cervical cancer cases from across the country to create a database of patients screened for HIV. Expand
Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Risk of incident SILs and likelihood of Pap test progression were increased among HIV-seropositive women with CD4(+) lymphocyte counts <500 cells/mm(3) and among women with human papillomavirus (HPV) infection, with risk-ordering from low- to high-risk HPV type. Expand
Incident and Persistent Vulvovaginal Candidiasis Among Human Immunodeficiency Virus–Infected Women: Risk Factors and Severity
Among HIV-infected women, lower CD4 count and higher HIV viral load were associated with vulvovaginal candidiasis, with strong associations for diabetes mellitus and pregnancy in particular. Expand
Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract.
- S. Cu-Uvin, J. Hogan, A. Caliendo, J. Harwell, K. Mayer, C. Carpenter
- Clinical infectious diseases : an official…
- 15 September 2001
Bacterial vaginosis was significantly associated with HIV-1 RNA expression in the female genital tract of HIV-infected women and the effect of lower genital tract infections on human immunodeficiency virus type 1 (HIV-1) RNA shedding in thefemale genital tract. Expand
The Effect of Highly Active Antiretroviral Therapy on Human Papillomavirus Clearance and Cervical Cytology
Close monitoring of women with HIV for cervical cytologic abnormalities, regardless of HAART treatment status, is warranted; among women with preexisting abnormal cervical cytology, HAART was associated with enhanced HPV clearance but not with Pap test regression. Expand